Get Live Data

Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

  2. Share Prices
  3. Avacta Group Share Price
  4. Avacta Group Share News
  5. UK Earnings, Trading Statements Calendar - Next 7 Days

Pin to quick picksAvacta Group Share News (AVCT)

Avacta Group Information

Share Price Information for Avacta Group (AVCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.75
Bid: 45.50
Ask: 46.00
Change: 1.00 (2.19%)
Spread: 0.50 (1.099%)
Open: 45.00
High: 46.75
Low: 44.25
Prev. Close: 45.75
AVCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Mon, 21st Sep 2020 16:08

Tuesday 22 September 
Judges Scientific PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Ergomed PLCHalf Year Results
ASA International Group PLCHalf Year Results
Alliance Pharma PLCHalf Year Results
Frenkel Topping Group PLCHalf Year Results
Parity Group PLCHalf Year Results
Bluefield Solar Income Fund LtdFull Year Results
Longboat Energy PLCHalf Year Results
NAHL GroupHalf Year Results
Tremor International LtdHalf Year Results
Litigation Capital Management LtdFull Year Results
Cambridge Cognition Holdings PLCHalf Year Results
Personal Group Holdings PLCHalf Year Results
Inspecs Group PLCHalf Year Results
Oriole Resources PLCHalf Year Results
Learning Technologies Group PLCHalf Year Results
Kingfisher PLCHalf Year Results
AG Barr PLCHalf Year Results
Town Centre SecuritiesFull Year Results
Mortgage Advice Bureau (Holdings) PLCHalf Year Results
ADES International Holding PLCHalf Year Results
Wednesday 23 September 
PZ Cussons PLCFull Year Results
Equals Group PLCHalf Year Results
Warpaint London PLCHalf Year Results
ECSC Group PLCHalf Year Results
Xeros Technology Group PLCHalf Year Results
LoopUp Group PLCHalf Year Results
CloudCall Group PLCHalf Year Results
Ten Entertainment Group PLCHalf Year Results
Origin Enterprises PLCFull Year Results
Staffline Group PLCHalf Year Results
Thursday 24 September 
CVS Group PLCFull Year Results
Smiths Group PLCFull Year Results
Go-Ahead Group PLCFull Year Results
SIG PLCHalf Year Results
GYG PLCHalf Year Results
Mitchells & Butlers PLCTrading Update
Safestay PLCHalf Year Results
Ebiquity PLCHalf Year Results
DFS Furniture PLCFull Year Results
Faron Pharmaceuticals LtdHalf Year Results
Pendragon PLCHalf Year Results
RTW Venture Fund LtdHalf Year Results
Cineworld Group PLCHalf Year Results
Funding Circle Hodlings PLCHalf Year Results
Baillie Gifford Shin Nippon PLCHalf Year Results
United Utilities Group PLCTrading Statement
Friday 25 September 
Camellia PLCHalf Year Results
Pennon Group PLCTrading Statement
Monday 28 September 
Brand Architekts Group PLCFull Year Results
7digital Group PLCHalf Year Results
Ceres Power Holdings PLCFull Year Results
Avacta Group PLCHalf Year Results
Instem PLCHalf Year Results
Chesnara PLCHalf Year Results
Reach PLCHalf Year Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
15 Dec 2021 08:24

Avacta antigen lateral flow test shown to detect Omicron

(Sharecast News) - Aim-listed Avacta said on Wednesday that its AffiDX® antigen lateral flow test has been shown to detect the Omicron variant of the SARS-CoV-2 virus in clinical samples.

Read more
29 Nov 2021 11:07

IN BRIEF: Avacta gets FDA nod to expand cancer drug trial into US

IN BRIEF: Avacta gets FDA nod to expand cancer drug trial into US

Read more
29 Nov 2021 10:38

FDA gives Avacta the go-ahead for US chemotherapy trials

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Monday that the US Food and Drug Administration (FDA) has approved its investigational new drug (IND) application for its chemotherapy drug 'AVA6000'.

Read more
2 Nov 2021 11:25

Avacta and Novacyt await UK regulatory approval for Covid-19 tests

Avacta and Novacyt await UK regulatory approval for Covid-19 tests

Read more
2 Nov 2021 10:21

Avacta suspends UK Covid test sales ahead of new approval

(Sharecast News) - Avacta said on Tuesday that it has suspended sales of its AffiDX Covid latest flow rapid antigen tests in the UK while it awaits new approval.

Read more
30 Sep 2021 11:14

Avacta hails "transformative" first half despite widening loss

Avacta hails "transformative" first half despite widening loss

Read more
30 Sep 2021 09:27

Avacta losses widen as development spend increases

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group reported cash and short-term deposits of £37m at the end of its first half on Thursday, down from £54.5m a year ago and £47.9m at the start of the period.

Read more
29 Sep 2021 10:32

Avacta sees pre-clinical development milestone in LG Chem partnership

Avacta sees pre-clinical development milestone in LG Chem partnership

Read more
29 Sep 2021 09:26

Avacta gets undisclosed milestone payment from LG Chem

(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Wednesday that a preclinical development milestone has been achieved in its multi-target therapeutics partnership with South Korea's LG Chem Life Sciences, triggering an undisclosed milestone payment.

Read more
23 Sep 2021 15:59

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Sep 2021 11:50

IN BRIEF: Avacta hires oncology drug developer as therapeutics CSO

IN BRIEF: Avacta hires oncology drug developer as therapeutics CSO

Read more
18 Aug 2021 14:26

IN BRIEF: Avacta hires cancer doctor Mark Goldberg for board

IN BRIEF: Avacta hires cancer doctor Mark Goldberg for board

Read more
11 Aug 2021 11:29

Avacta doses first patient in chemotherapy medication trial

Avacta doses first patient in chemotherapy medication trial

Read more
11 Aug 2021 10:00

First patient dosed in Avacta's 'AVA6000' trial

(Sharecast News) - Clinical-stage oncology drug company Avacta Group announced on Wednesday that the first patient has been dosed in its phase 1 multicentre trial evaluating 'AVA6000', which it described as a "novel pro-drug" of 'doxorubicin', and its first therapeutic product based on the proprietary 'preCISION' technology.

Read more
4 Aug 2021 17:53

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts

IN BRIEF: Shipment of Avacta's Covid-19 lateral flow test starts

Read more
34567891011

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.